Emerald Advisers, LLC Insmed Inc Transaction History

Emerald Advisers, LLC

  • $2.41 Billion
  • Q3 2024

A detailed history of Emerald Advisers, LLC transactions in Insmed Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 689,807 shares of INSM stock, worth $50.9 Million. This represents 2.09% of its overall portfolio holdings.

Number of Shares
689,807
Previous 640,267 7.74%
Holding current value
$50.9 Million
Previous $42.9 Million 17.39%
% of portfolio
2.09%
Previous 1.92%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
BUY
$62.0 - $79.01 $3.07 Million - $3.91 Million
49,540 Added 7.74%
689,807 $50.4 Million
Q2 2024

Aug 06, 2024
BUY
$22.0 - $69.71 $221,936 - $703,234
10,088 Added 1.6%
640,267 $42.9 Million
Q1 2024

May 08, 2024
SELL
$25.72 - $29.94 $7.73 Million - $9 Million
-300,670 Reduced 32.3%
630,179 $17.1 Million
Q4 2023

Feb 05, 2024
SELL
$23.42 - $31.74 $156,141 - $211,610
-6,667 Reduced 0.71%
930,849 $28.8 Million
Q3 2023

Oct 26, 2023
SELL
$19.86 - $26.93 $1.02 Million - $1.39 Million
-51,510 Reduced 5.21%
937,516 $23.7 Million
Q2 2023

Jul 25, 2023
SELL
$16.44 - $21.1 $28,868 - $37,051
-1,756 Reduced 0.18%
989,026 $20.9 Million
Q1 2023

May 04, 2023
SELL
$16.26 - $21.73 $67,170 - $89,766
-4,131 Reduced 0.42%
990,782 $16.9 Million
Q4 2022

Feb 03, 2023
BUY
$16.98 - $23.15 $16.9 Million - $23 Million
994,913 New
994,913 $19.9 Million
Q1 2020

Apr 30, 2020
SELL
$13.63 - $33.98 $9.19 Million - $22.9 Million
-674,167 Closed
0 $0
Q4 2019

Jan 29, 2020
SELL
$16.12 - $24.98 $5.01 Million - $7.76 Million
-310,820 Reduced 31.56%
674,167 $16.1 Million
Q3 2019

Oct 31, 2019
BUY
$15.49 - $25.78 $1.08 Million - $1.79 Million
69,468 Added 7.59%
984,987 $17.4 Million
Q2 2019

Jul 31, 2019
SELL
$23.0 - $32.19 $138,184 - $193,397
-6,008 Reduced 0.65%
915,519 $23.4 Million
Q1 2019

May 01, 2019
BUY
$13.91 - $31.15 $4.43 Million - $9.92 Million
318,482 Added 52.81%
921,527 $26.8 Million
Q4 2018

Jan 30, 2019
SELL
$11.6 - $18.7 $2.19 Million - $3.52 Million
-188,429 Reduced 23.81%
603,045 $7.91 Million
Q3 2018

Oct 31, 2018
BUY
$18.95 - $28.08 $1.38 Million - $2.04 Million
72,585 Added 10.1%
791,474 $16 Million
Q2 2018

Jul 31, 2018
SELL
$20.0 - $29.72 $161,140 - $239,454
-8,057 Reduced 1.11%
718,889 $17 Million
Q1 2018

Apr 26, 2018
SELL
$21.69 - $32.99 $2.86 Million - $4.36 Million
-132,065 Reduced 15.37%
726,946 $16.4 Million
Q4 2017

Feb 05, 2018
SELL
$26.43 - $31.78 $107,358 - $129,090
-4,062 Reduced 0.47%
859,011 $26.8 Million
Q3 2017

Oct 30, 2017
BUY
$11.61 - $31.21 $10 Million - $26.9 Million
863,073
863,073 $26.9 Million

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email